TRIAL INFORMATION

Hypoactive Sexual Desire Disorder for Post Menopausal Women 50 or older
Call (860) 443-4567 - Coastal Connecticut Research in New London, CT

SUMMARY: A medical research study is underway for women who are concerned about their decreased sexual desire. For many women, decreased sexual desire is often an unfortunate consequence of menopause and can lead to feelings of unhappiness, concern and frustration and can impact a woman’s relationship with her partner. Hypoactive Sexual Desire Disorder (HSDD) is the most common form of female dysfunction. The condition is typically identified by decreased or absent sexual fantasies and desire for sex – and the exact cause is unknown.


STUDY DESCRIPTION: The study will help evaluate the long-term safety and efficacy of daily topical applications of LibiGel, an investigational drug, compared to placebo gel (an inactive substance) in the treatment of Hypoactive Sexual Desire Disorder in postmenopausal women. The study consists of a screening period of up to 4 weeks and a 60-month treatment period. Subjects will complete 9 office visits and 5 telephone contacts during the course of the study. Also, the study will follow subjects for heart blood vessel disease events and breast cancers for up to 5 years.

Inclusion Criteria:

• Natural menopausal women 50 years of age or older with a diagnosis of HSDD

• Subjects with hysterectomy only must meet following menopause criteria: 50 to 54 years must be experiencing hot flushes or receiving estrogen therapy for hot flashes

• At least one risk factor for heart blood vessel disease including: 70 years or greater, type 2 diabetes, high blood pressure, smoking, or taking medication to treat high blood pressure

• Agrees to provide research site with contact information throughout the study period, which will last up to 5 years

• Additional inclusion and exclusion criteria apply and will be reviewed with you.

Disclosure/Rights
Before participating in a study, the study is explained to you in detail, including the advantages and the side effects of each medication and your time commitment. You are also given a detailed consent form to read. If you desire, Coastal Connecticut Research will notify any of your physicians about your participation.
During the course of the study, Dr. Spitz and his staff are always available to answer any questions. Your privacy is protected, and your medical records are confidential. You are free to discontinue the study at any time for any reason.
For more information, please contact Carolyn at Coastal Connecticut Research In New London, CT (860) 443-4567. All clinicians are board certified gynecologists and nurse practioners.

For more information log into www.CCRvolunteer.com
Participating Clinical Research Investigators:
Dr. Robert M. Spitz
Dr. Timothy Barczak
Merrilyn McNatt, APRN
Eileen O'Donnell, APRN
Kathy Bryson, APRN
Alyce Hemstreet, CS, APRN

• Location: New London

• Compensation: Eligible participants will receive up to $450.00

• This is a part-time job.

• Principals only. Recruiters, please don't contact this job poster.

• Please, no phone calls about this job!

• Please do not contact job poster about other services, products or commercial interests.

Original URL: http://newlondon.craigslist.org/etc/619517720.html